Dr. Reddy’s in licenses biosimilar for J&J’s multiple myeloma therapy
Dr. Reddy's (RDY) partners with Shanghai Henlius Biotech to develop and market biosimilar versions of J&J's (JNJ) multiple ...
CARsgen's First Enrolled Subject in the THANK-u Plus™ Platform-Based Allogeneic CAR-T Trial Achieves sCR at Week 4
CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the ...
The American Journal of Managed Care2d
Prolonged Survival in MM: Insights from the Largest Ongoing US Registry
The Connect MM Registry is the longest-running and largest registry in the US, providing invaluable prognostic insights into ...
technologynetworks13h
Gene Modification Could Improve Immune Cells’ Ability To Combat Cancer
A new study reveals that modifying the CUL5 gene enhances CAR-T cell therapy for leukemia and lymphoma. This improves cell ...
GlobalData on MSN3d
Dr Reddy’s and Shanghai Henlius sign agreement for HLX15
Dr Reddy's Laboratories has signed a licence agreement with Shanghai Henlius Biotech to develop and commercialise HLX15.
Medscape3d
Sequential or Combination Therapy for Multiple Myeloma
S Lional is supported by the Richard and Annelly Deets Fund for Multiple Myeloma and acts as a consultant ... of this manuscript. Sequential therapy refers to treatment with drug regimens ...
Why Legend Biotech Corporation (LEGN) Is Among the Best Healthcare Stocks To Buy According to Analysts
We recently compiled a list of the 12 Best Healthcare Stocks to Buy According to Analysts. In this article, we are going to ...
Rare bone marrow transplant patient completed at Baton Rouge hospital
Our Lady of the Lake Cancer Institute is celebrating after successfully completing a bone marrow transplant so rare it has ...
Upstate cancer survivor celebrates recovery with innovative CAR T-cell treatment
On this World Cancer Day, Chris Vogelsang, a cancer survivor from upstate New York, is celebrating his recovery thanks to a ...
Daily3d
Dr Reddy's Labs inks pact with Henlius for commercialization of multiple myeloma injection HLX15 in US, Europe
Hyderabad: Dr Reddy's Laboratories SA, a wholly-owned subsidiary of Dr. Reddy's Laboratories Ltd. has announced that it has ...